Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients
Atanasova, Elena, Milosevic, Dragana, Bornschlegl, Svetlana, Krucker, Karen P, Jacob, Eapen K, Carmona Porquera, Eva M, Anderson, Dagny K, Egan, Ashley M, Limper, Andrew H, Dietz, Allan B
Published in Stem cell research & therapy (31.01.2022)
Published in Stem cell research & therapy (31.01.2022)
Get full text
Journal Article